Zobrazeno 1 - 10
of 11
pro vyhledávání: '"F. Mondout"'
Autor:
Arnaud Bisson, L Fauchier, D Babuty, Bertrand Pierre, Alexandre Bodin, L Guillon Grammatico, C Gaborit, Julien Herbert, F Mondout, Nicolas Clementy
Publikováno v:
European Heart Journal. 40
Catheter ablation for atrial fibrillation (AF) is a validated therapy for patients with symptomatic AF to prevent recurrences. The CASTLE AF trial indicated that ablation for AF in patients with heart failure was associated with a lower rate of death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3544f3d25d7b6b448d68f339defbcc9
https://doi.org/10.1093/eurheartj/ehz747.0012
https://doi.org/10.1093/eurheartj/ehz747.0012
Autor:
F Mondout, Michele Brignole, Bertrand Pierre, D Babuty, L Fauchier, Jean-Claude Deharo, Alexandre Bodin, Nicolas Clementy, Arnaud Bisson
Publikováno v:
European Heart Journal. 40
Atrial fibrillation (AF) catheter ablation is a validated therapy for patients with symptomatic AF after failure or intolerance to antiarrhythmic drug therapy. Despite improvements in ablation technique, 30 to 50% of the patients may have AF recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0df3e07b1b2dd3e299b8730156e6c96d
https://doi.org/10.1093/eurheartj/ehz746.1164
https://doi.org/10.1093/eurheartj/ehz746.1164
Autor:
L Fauchier, D Babuty, Bertrand Pierre, C Gaborit, F Mondout, Arnaud Bisson, L Guillon Grammatico, Julien Herbert, Nicolas Clementy
Publikováno v:
European Heart Journal. 40
Background Catheter ablation for atrial fibrillation (AF) is a validated therapy for patients with symptomatic AF to prevent recurrences. The CASTLE AF trial indicated that ablation for AF in patients with heart failure (HF) was associated with a low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9e71ab12e28bf752bb34b727aeed474
https://doi.org/10.1093/eurheartj/ehz747.0135
https://doi.org/10.1093/eurheartj/ehz747.0135
Autor:
Denis Angoulvant, E. Vermes-Otmani, F. Mondout, David Ternant, T Genet, Theodora Bejan-Angoulvant, Fabrice Ivanes, Stéphanie Chadet
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 12:9
Background Infarct size, a key prognostic factor in ST-segment elevation myocardial infarction (STEMI), is best assessed by late gadolinium enhancement in cardiac magnetic resonance imaging (MRI). MRI availability being limited, necrosis biomarkers (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b4d9ed500facf00364f2dc5216d1b2c
https://doi.org/10.1016/j.acvdsp.2019.09.011
https://doi.org/10.1016/j.acvdsp.2019.09.011
Autor:
Nicolas Clementy, Clémentine André, Bertrand Pierre, F Mondout, L Fauchier, Alexandre Bodin, Dominique Babuty, Arnaud Bisson
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98e335109f357464f3164d1ee37ddf1e
https://doi.org/10.1093/eurheartj/ehy566.p6083
https://doi.org/10.1093/eurheartj/ehy566.p6083
Autor:
Dominique Babuty, Alexandre Bodin, Arnaud Bisson, F Mondout, Nicolas Clementy, L Fauchier, Clémentine André, Bertrand Pierre
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74ca263bde56d41f7e50c720f962e854
https://doi.org/10.1093/eurheartj/ehy566.p6230
https://doi.org/10.1093/eurheartj/ehy566.p6230
Autor:
Clémentine André, Arnaud Bisson, Dominique Babuty, Bertrand Pierre, Nicolas Clementy, Alexandre Bodin, L Fauchier, F Mondout
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b663e96b8346949147594dc88fef9f89
https://doi.org/10.1093/eurheartj/ehy566.5050
https://doi.org/10.1093/eurheartj/ehy566.5050
Autor:
Clémentine André, Bertrand Pierre, F Mondout, Nicolas Clementy, L Fauchier, Alexandre Bodin, Dominique Babuty, Arnaud Bisson
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a317ee98a0f794495f8460f1afa276f5
https://doi.org/10.1093/eurheartj/ehy566.p6657
https://doi.org/10.1093/eurheartj/ehy566.p6657
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:275
Introduction Infarct size (IS) is a key determinant of cardiovascular events and is ideally assessed by cardiac MRI. MRI availability is limited and many studies used necrosis biomarkers (CK, troponin) as a surrogate marker of IS by determination of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0099de574d84f8f3efa9912141fc9553
https://doi.org/10.1016/j.acvdsp.2019.02.198
https://doi.org/10.1016/j.acvdsp.2019.02.198
Autor:
L Fauchier, Alexandre Bodin, F Mondout, Bertrand Pierre, Dominique Babuty, C Gaborit, Clémentine André, Arnaud Bisson, Nicolas Clementy
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 11:119
Background Atrial fibrillation (AF) may commonly be associated with sinus node disease (SND) presenting as the so-called bray-tachy syndrome (BTS). BTS and AF are known to be at risk for ischemic stroke (IS). It remains unclear whether the risk of IS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b3dc13527e374ae02aa0f020dd0c999
https://doi.org/10.1016/j.acvdsp.2018.10.263
https://doi.org/10.1016/j.acvdsp.2018.10.263